Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027?
One-OffHealth & MedicineCiência1a
Manifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoPrevisão da comunidade atual
Não 76.9%
Previsores
7
Tipo de pergunta
binary
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Dados do mercado
Atualizado há 19 horas
Desatualizado17/01/24, 01:47 UTC1/01/28, 04:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will China have more phase 3 drug trials than the United States in year X?
Manifold MarketsWill BioAge's BGE-102 achieve its primary endpoint in the Phase 2 QUELL-CV trial before January 1, 2028?
Manifold MarketsIf I choose to undergo past life regression therapy, what will I have been?
Manifold MarketsTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurHow many clinical trials will have started in Prospera by Dec 31, 2026?
FutuurWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRegras
Os critérios de resolução ainda não estão disponíveis para este mercado. Esta seção será preenchida nas próximas atualizações quando as regras da fonte forem armazenadas.
Mercados abertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 35,6 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Volume total
- € 1,6 mi
- Volume 24h
- € 5,2 mil
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Volume total
- € 83,5 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 mais resultados
- Volume total
- € 864,2 mil
- Volume 24h
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- € 915,8 mil
- Volume 24h
- € 1,5 mil
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Volume total
- € 4,2 mil
- Volume 24h
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
Perguntas frequentes
- Quais são as probabilidades atuais de Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027??
- A Manifold Markets cota No em 77% em 8 de setembro de 2026.
- Quando Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? é resolvido?
- Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? deverá ser resolvido em 1 de janeiro de 2028.